Congenital sucrase-isomaltase deficiency
Other Names for this Disease
- Congenital sucrase-isomaltose malabsorption
- Congenital sucrose intolerance
- Congenital sucrose-isomaltase malabsorption
- Disaccharide intolerance
On this page
CSID is typically treated by modifying a person's diet to reduce the amount of sucrose. Because many foods contain sucrose and other complex sugars, it can be difficult to completely remove sucrase from the diet. Sucraid is an oral medication containing the enzyme that does not work properly in people with this condition. By taking this medication, those with CSID can eat sucrose-containing foods because this enzyme will break down sucrose. This medication must be taken with each meal or snack.
Last updated: 7/5/2013
- Congenital sucrase-isomaltase deficiency . Madisons Foundation. September 2007; http://www.madisonsfoundation.org/index.php?option=com_mpower&task=disease&diseaseID=663. Accessed 7/5/2013.
- ClinicalTrials.gov lists trials that are studying or have studied Congenital sucrase-isomaltase deficiency. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
(QOL Medical, LLC)
The FDA has approved this product to be used in this manner.
|Oral replacement therapy of the genetically determined sucrase deficiency, which is part of congenital sucrease-isomaltase deficiency.|
|More Information about this product||Drug Information Portal|